Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China
· Delayed Price · Currency is CNY 26.34
+0.16 (0.61%)
Mar 10, 2026, 10:15 AM CST
SHA:600993 Revenue
Mayinglong Pharmaceutical Group had revenue of 888.26M CNY in the quarter ending September 30, 2025, with 2.80% growth. This brings the company's revenue in the last twelve months to 3.77B, up 8.36% year-over-year. In the year 2024, Mayinglong Pharmaceutical Group had annual revenue of 3.73B with 18.85% growth.
Revenue (ttm)
3.77B
Revenue Growth
+8.36%
P/S Ratio
2.99
Revenue / Employee
1.42M
Employees
2,654
Market Cap
11.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | 591.28M | 18.85% |
| Dec 31, 2023 | 3.14B | -395.63M | -11.20% |
| Dec 31, 2022 | 3.53B | 147.32M | 4.35% |
| Dec 31, 2021 | 3.39B | 593.47M | 21.26% |
| Dec 31, 2020 | 2.79B | 86.20M | 3.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Porton Pharma Solutions | 3.43B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Zhejiang CONBA Pharmaceutical | 6.58B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 5.49B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Henan Lingrui Pharmaceutical | 3.78B |